Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kramar

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Increased estrogen receptor betacx expression during mammary carcinogenesisMajida Esslimani-Sahla, Andrew Kramar, Joelle Simony-Lafontaine, et al.
Critical Reviews in Oncology/Hematology|January 10, 2012
Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic modelsAnne Ploquin, David Olmos, Charles Ferté, et al.
Breast Cancer Research and Treatment|November 1, 2002
Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapyPierre-Jean Lamy, Pascal Pujol, Simon Thezenas, et al.
Clinical Genitourinary Cancer|September 6, 2016
A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell TumorsSerge M A Somda, Stéphane Culine, Christine Chevreau, et al.
International Journal of Cancer|October 18, 2006
Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesisMajida Esslimani-Sahla, Simon Thezenas, Joelle Simony-Lafontaine, et al.
Breast Cancer Research and Treatment|July 11, 2015
A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapyEmilie Le Rhun, Xavier Delbeuck, Claudia Lefeuvre-Plesse, et al.
Bulletin Du Cancer|May 30, 2012
Failure event types and prognostic factors after node-positive breast cancer in patients treated by adjuvant chemotherapy: impact on follow-upThomas Filleron, Andrew Kramar, Florence Dalenc, et al.
Journal of Surgical Oncology|January 13, 2016
Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trialJean-Louis Houpeau, Marie-Pierre Chauvet, François Guillemin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2015
Lobulated enhancement evaluation in the follow-up of liver metastases treated by stereotactic body radiation therapyHajer Jarraya, Paul Borde, Xavier Mirabel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trialAnja Lorch, Antje Kleinhans, Andrew Kramar, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Increased estrogen receptor betacx expression during mammary carcinogenesisMajida Esslimani-Sahla, Andrew Kramar, Joelle Simony-Lafontaine, et al.
Critical Reviews in Oncology/Hematology|January 10, 2012
Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic modelsAnne Ploquin, David Olmos, Charles Ferté, et al.
Breast Cancer Research and Treatment|November 1, 2002
Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapyPierre-Jean Lamy, Pascal Pujol, Simon Thezenas, et al.
Clinical Genitourinary Cancer|September 6, 2016
A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell TumorsSerge M A Somda, Stéphane Culine, Christine Chevreau, et al.
International Journal of Cancer|October 18, 2006
Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesisMajida Esslimani-Sahla, Simon Thezenas, Joelle Simony-Lafontaine, et al.
Breast Cancer Research and Treatment|July 11, 2015
A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapyEmilie Le Rhun, Xavier Delbeuck, Claudia Lefeuvre-Plesse, et al.
Bulletin Du Cancer|May 30, 2012
Failure event types and prognostic factors after node-positive breast cancer in patients treated by adjuvant chemotherapy: impact on follow-upThomas Filleron, Andrew Kramar, Florence Dalenc, et al.
Journal of Surgical Oncology|January 13, 2016
Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trialJean-Louis Houpeau, Marie-Pierre Chauvet, François Guillemin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2015
Lobulated enhancement evaluation in the follow-up of liver metastases treated by stereotactic body radiation therapyHajer Jarraya, Paul Borde, Xavier Mirabel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trialAnja Lorch, Antje Kleinhans, Andrew Kramar, et al.
Pageof 9